Click a link below to view the mailing archive as if it had been sent to you.
| 2020-10-30 12:15 | | The doctor will Zoom you now: Pharma execs talk ins and outs of telehealth and more... |
| 2020-10-30 00:15 | | Moderna says it’s preparing global launch of Covid vaccine as it takes in $1.1 billion in deposits and more... |
| 2020-10-29 12:15 | | Novartis sharpens focus on vision-restoring gene therapy with $150M Vedere buyout |
| 2020-10-29 00:15 | | Documents show Sackler family's involvement in opioid operations and more... |
| 2020-10-28 12:15 | | Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger and more... |
| 2020-10-28 00:15 | | Kala Gets the Greenlight from FDA for Dry Eye Disease Treatment and more... |
| 2020-10-27 12:15 | | A month after Illumina's big Grail buyout, Exact Sciences scoops up liquid biopsy rival Thrive for a relative bargain and more... |
| 2020-10-27 00:15 | | Eli Lilly Ends Covid-19 Antibody Trial After Finding It’s Unlikely To Help Hospitalized Patients and more... |
| 2020-10-26 12:15 | | Bayer to buy AskBio for $2B in bid to become a gene therapy player and more... |
| 2020-10-26 00:15 | | Closely Watched Mirati Reveals Results to Rival Amgen Drug and more... |
| 2020-10-25 00:15 | | FDA’s COVID-19 vaccine adcomm raises questions as first readouts loom and more... |
| 2020-10-23 12:15 | | Foghorn hits Nasdaq in $120M debut as the biotech IPO boom shows no sign of slowing and more... |
| 2020-10-23 00:15 | | Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus and more... |
| 2020-10-22 12:15 | | Pfizer, Moderna COVID-19 vaccines could reach all Americans by June—if politics don't get in the way: Slaoui and more... |
| 2020-10-22 00:15 | | FDA’s COVID-focused vaccines adcomm: A preview and more... |
| 2020-10-21 12:15 | | US officials: OxyContin maker to plead to 3 criminal charges and more... |
| 2020-10-21 00:15 | | U.S. Trial With AstraZeneca's Coronavirus Vaccine Expected to Resume Soon and more... |
| 2020-10-20 12:15 | | MD Anderson establishes new $50M+ biotech fund to choose the next promising cancer therapies and more... |
| 2020-10-20 00:15 | | Oncology research mid-pandemic: Challenges may bring durable innovation and more... |
| 2020-10-19 12:15 | | Pfizer CEO Anticipates EUA for COVID-19 Vaccine in Late November and more... |
| 2020-10-19 00:15 | | FDA reissues Chinese respirator EUA, but freezes new additions and more... |
| 2020-10-18 12:15 | | Early signs of survival benefit raise optimism around a small biotech's ALS drug |
| 2020-10-18 00:15 | | The two months in 1980 that shaped the future of biotech and more... |
| 2020-10-17 00:15 | | 5 questions ahead of next week's FDA meeting on coronavirus vaccines and more... |
| 2020-10-16 12:15 | | Pfizer to apply for COVID-19 vaccine EUA after mid-November safety data milestone and more... |
| 2020-10-16 00:15 | | COVID-19 mRNA vaccine candidate from Sanofi and Translate protects mice, monkeys: study and more... |
| 2020-10-15 12:15 | | It’s Raining Biotech SPACs! and more... |
| 2020-10-15 00:15 | | Vertex faces first notable setback as it pushes beyond cystic fibrosis and more... |
| 2020-10-14 12:15 | | What The Pause In The Johnson & Johnson And Eli Lilly Covid Drug Trials May Mean and more... |
| 2020-10-14 00:15 | | Vaxart begins early-stage trial of oral COVID-19 vaccine candidate and more... |
| 2020-10-13 12:15 | | Months after retiring from Genentech, Michael Varney brings his drug hunting eye to Frazier and more... |
| 2020-10-13 00:15 | | Study: Few new drugs have high therapeutic value and more... |
| 2020-10-12 12:15 | | Drowning in litigation, Mallinckrodt becomes third opioid producer to file for bankruptcy and more... |
| 2020-10-12 00:15 | | Steris to acquire Key Surgical for $850M and more... |
| 2020-10-11 00:15 | | 4 Biotech IPOs this Week: Kronos, Shattuck, Spruce and Aziyo and more... |
| 2020-10-09 12:15 | | Gilead's remdesivir shaved five days off COVID-19 recovery time, reduced risk of death in some and more... |
| 2020-10-09 00:15 | | COVID-19 vaccine trial recruiters explain widespread distrust, misinformation among potential enrollees and more... |
| 2020-10-08 12:15 | | Regeneron submits request for EUA for COVID-19 antibody cocktail and more... |
| 2020-10-08 00:15 | | Bristol Myers Squibb Announces Phase III Results Exploring the Potential of Opdivo and more... |
| 2020-10-07 12:15 | | Nobel Prize in chemistry goes to CRISPR pioneers Doudna, Charpentier and more... |
| 2020-10-07 00:15 | | FDA releases coronavirus vaccine guidelines that White House resisted and more... |
| 2020-10-06 12:15 | | White House ignoring, unlikely to approve FDA's new COVID-19 vaccine guidelines and more... |
| 2020-10-06 00:15 | | European Medicines Agency reviewing reports of kidney injury in patients taking Gilead's remdesivir and more... |
| 2020-10-05 12:15 | | Bristol Myers to buy MyoKardia in $13B bet on targeted drugs for the heart and more... |
| 2020-10-05 00:15 | | What If Pfizer's and Moderna's Coronavirus Vaccine Results Are Delayed? and more... |
| 2020-10-04 12:15 | | President Trump Begins Treatment With Remdesivir from Gilead Sciences and more... |
| 2020-10-03 00:15 | | This Late-to-the-Party Coronavirus Vaccine Maker Could Be the Biggest Winner Over the Long Run and more... |
| 2020-10-02 00:15 | | Flame Biosciences to Ignite Pipeline with $100M Common Stock Financing and more... |
| 2020-10-01 12:15 | | Novartis, Amgen and Mallinckrodt used aggressive price hikes to meet sales goals, congressional probe finds and more... |
| 2020-10-01 00:15 | | Congressional investigation reveals Celgene, Teva plotted to keep drug prices high and more... |
